Merck (NYSE:MRK), known as MSD outside Canada and the United States, announced today it has entered into an agreement with Thermo Fisher Scientific to manufacture molnupiravir, Merck's investigational
1847 Holdings LLC ("1847" or the "Company") (NYSE:EFSH), a unique holding company that combines the attractive attributes of owning private, lower-middle market businesses with the liquidity and